Davide Capodanno (D Capodanno)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 46

Top Topics

Transcatheter Aortic Valve Implantation

Antiplatelet Therapy

Percutaneous Coronary Intervention

St Segment Elevation Myocardial Infarction

Top Venues

European heart journal

Expert review of cardiovascular therapy

European heart journal supplements : journal of the European Society of Cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Carla Rochira, Davide Capodanno
DOACs and rheumatic valvulopathy: always a red light? European heart journal supplements : journal of the European Society of Cardiology 25 (Suppl B) (2023)
Davide Capodanno, Dominick J Angiolillo
Long-Term P2Y 12 Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention. Circulation 147 (2) (2023)
Mattia Galli, Renzo Laborante, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Domenico D'Amario, Davide Capodanno, Elena Tremoli, Charles Micheal Gibson, Roxana Mehran, Dominick J Angiolillo
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis. Thrombosis and haemostasis (2023)
Antonio Greco, Simone Finocchiaro, Dominick J Angiolillo, Davide Capodanno
Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Expert opinion on pharmacotherapy (2023)
Carla Rochira, Davide Capodanno
DOACs and rheumatic valvulopathy: always a red light? European heart journal supplements : journal of the European Society of Cardiology 25 (Suppl B) (2023)
Eliano Pio Navarese, Antonio Landi, Angelo Oliva, Raffaele Piccolo, Victor Aboyans, Dominick Angiolillo, Dan Atar, Davide Capodanno, Keith A A Fox, Sigrun Halvorsen, Stefan James, Peter Jüni, Vijay Kunadian, Sergio Leonardi, Roxana Mehran, Gilles Montalescot, Josef Niebauer, Susanna Price, Robert F Storey, Heinz Völler, Pascal Vranckx, Stephan Windecker, Marco Valgimigli
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease. Two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC) and European Association of Preventive Cardiology (EAPC). European heart journal. Cardiovascular pharmacotherapy (2023)
Robert A Byrne, Stephen E Fremes, Davide Capodanno, Martin Czerny, Torsten Doenst, Jonathan R Emberson, Volkmar Falk, Mario F L Gaudino, John Joseph Valentine McMurray, Roxana Mehran, Milan Milojevic, Miguel Sousa Uva
2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 64 (2) (2023)
Davide Capodanno, Roxana Mehran, Mitchell W Krucoff, Usman Baber, Deepak L Bhatt, Piera Capranzano, Jean-Philippe Collet, Thomas Cuisset, Giuseppe De Luca, Leonardo De Luca, Andrew Farb, Francesco Franchi, C Michael Gibson, Joo-Yong Hahn, Meyong-Ki Hong, Stefan K James, Adnan Kastrati, Takeshi Kimura, Pedro Alves Lemos Neto, Renato Deláscio Lopes, Adrian Magee, Ryosuke Matsumura, Shuichi Mochizuki, Michelle L O'Donoghue, Naveen L Pereira, Sunil V Rao, Fabiana Rollini, Yuko Shirai, Dirk Sibbing, Pieter C Smits, Phillippe Gabriel Steg, Robert F Storey, Jurrien M Ten Berg, Marco Valgimigli, Pascal Vranckx, Hirotoshi Watanabe, Stephan Windecker, Patrick W J C Serruys, Robert W Yeh, Marie-Claude Morice, Dominick J Angiolillo
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium. Circulation 147 (25) (2023)
Antonio Greco, Claudio Laudani, Marco Spagnolo, Federica Agnello, Denise Cristiana Faro, Simone Finocchiaro, Marco Legnazzi, Maria Sara Mauro, Placido Maria Mazzone, Giovanni Occhipinti, Carla Rochira, Lorenzo Scalia, Davide Capodanno
Pharmacology and Clinical Development of Factor XI Inhibitors. Circulation 147 (11) (2023)
Placido Maria Mazzone, Davide Capodanno
Low dose rivaroxaban for the management of atherosclerotic cardiovascular disease. Journal of thrombosis and thrombolysis (2023)
Davide Landolina, Nicola Ammirabile, Davide Capodanno
Strategies for Tailored Antiplatelet Therapy After PCI: Unraveling Complexities, Embracing Nuances. Thrombosis and haemostasis (2023)
Nicola Ammirabile, Davide Landolina, Davide Capodanno
Navigating the Course of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Review of Guided Approaches. Circulation. Cardiovascular interventions (2023)
Davide Capodanno, Claudio Laudani
Unraveling the Maze of De-Escalation Strategies in Acute Coronary Syndromes. Circulation. Cardiovascular interventions (2023)
Carla Rochira, Davide Capodanno
DOACs and rheumatic valvulopathy: always a red light? European heart journal supplements : journal of the European Society of Cardiology 25 (Suppl B) (2023)
Marco Valgimigli, Adrian Wlodarczak, Ralph Tölg, Bela Merkely, Henning Kelbæk, Ewa Ł Stępień, Stefano Galli, Matthieu Godin, Gabor G Toth, Thibault Lhermusier, Benjamin Honton, Peter Laurenz Dietrich, Francis Stammen, Bert Ferdinande, Johanne Silvain, Davide Capodanno, Guillaume Cayla, null null
Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial. Circulation (2023)
Antonio Greco, Simone Finocchiaro, Dominick J Angiolillo, Davide Capodanno
Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Expert opinion on pharmacotherapy (2023)
Davide Cao, Nicolas Amabile, Mauro Chiarito, Victoria T Lee, Dominick J Angiolillo, Davide Capodanno, Deepak L Bhatt, Michael J Mack, Robert F Storey, Michael Schmoeckel, C Michael Gibson, Efthymios N Deliargyris, Roxana Mehran
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding. European heart journal (2023)
Marco Valgimigli, Victor Aboyans, Dominick Angiolillo, Dan Atar, Davide Capodanno, Sigrun Halvorsen, Stefan James, Peter Jüni, Vijay Kunadian, Antonio Landi, Sergio Leonardi, Roxana Mehran, Gilles Montalescot, Eliano Pio Navarese, Josef Niebauer, Angelo Oliva, Raffaele Piccolo, Susanna Price, Robert F Storey, Heinz Völler, Pascal Vranckx, Stephan Windecker, Keith A A Fox
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease: 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Association for Acute CardioVascular Care (ACVC) and European Association of Preventive Cardiology (EAPC). European heart journal. Cardiovascular pharmacotherapy (2023)
Robert A Byrne, Stephen E Fremes, Davide Capodanno, Martin Czerny, Torsten Doenst, Jonathan R Emberson, Volkmar Falk, Mario F L Gaudino, John Joseph Valentine McMurray, Roxana Mehran, Milan Milojevic, Miguel Sousa Uva
2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG. European heart journal (2023)
Mattia Galli, Renzo Laborante, Giovanni Occhipinti, Andea Zito, Luigi Spadafora, Giuseppe Biondi-Zoccai, Roberto Nerla, Fausto Castriota, Domenico D'Amario, Davide Capodanno, Young Hoon Jeong, Takeshi Kimura, Roxana Mehran, Dominick J Angiolillo
Impact of Ethnicity on Antiplatelet Treatment Regimens for Bleeding Reduction in Acute Coronary Syndromes: A Systematic Review and Pre-specified Subgroup Meta-analysis. European heart journal. Cardiovascular pharmacotherapy (2023)
Mattia Galli, Renzo Laborante, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Domenico D'Amario, Davide Capodanno, Elena Tremoli, C Michael Gibson, Roxana Mehran, Dominick J Angiolillo
Factor XI inhibitors in early clinical trials: a meta-analysis. Thrombosis and haemostasis (2023)
Davide Capodanno, Dominick J Angiolillo
Long-Term P2Y 12 Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention. Circulation 147 (2) (2023)
Davide Capodanno, Dominick J Angiolillo
Long-Term P2Y 12 Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention. Circulation 147 (2) (2023)
Davide Capodanno, Antonio Greco
Dual antiplatelet therapy in patients at high bleeding risk: less is more-more or less. European heart journal 44 (11) (2023)
Antonio Greco, Claudio Laudani, Marco Spagnolo, Federica Agnello, Denise Cristiana Faro, Simone Finocchiaro, Marco Legnazzi, Maria Sara Mauro, Placido Maria Mazzone, Giovanni Occhipinti, Carla Rochira, Lorenzo Scalia, Davide Capodanno
Pharmacology and Clinical Development of Factor XI Inhibitors. Circulation 147 (11) (2023)
Gill Louise Buchanan, Valeria Paradies, Nicole Karam, Lene Holmvang, Mamas A Mamas, Julinda Mehilli, Davide Capodanno, Piera Capranzano, Yolande Appelman, Stéphane Manzo-Silberman, Vijay Kunadian, Josepa Mauri, Stefanie Shuepke, Anna Sonia Petronio, Marta Kaluzna-Oleksy, Martine Gilard, Marie Claude Morice, Emanuele Barbato, Dariusz Dudek, Alaide Chieffo
Overcoming professional barriers encountered by women in interventional cardiology: an EAPCI statement. European heart journal (2023)
Carla Rochira, Davide Capodanno
DOACs and rheumatic valvulopathy: always a red light? European heart journal supplements : journal of the European Society of Cardiology 25 (Suppl B) (2023)
Davide Capodanno, Dominick J Angiolillo
Personalised antiplatelet therapies for coronary artery disease: what the future holds. European heart journal (2023)
Antonio Greco, Marco Spagnolo, Davide Capodanno
Antithrombotic therapy after transcatheter aortic valve implantation. Expert review of medical devices 19 (6) (2022)
Federica Agnello, Davide Capodanno
Anti-inflammatory strategies for atherosclerotic artery disease. Expert opinion on drug safety 21 (5) (2022)
Placido Maria Mazzone, Dominick J Angiolillo, Davide Capodanno
Approaches to de-escalation of antiplatelet treatment in stabilized post-myocardial infarction patients with high ischemic risk. Expert review of cardiovascular therapy 20 (10) (2022)
Lorenzo Scalia, Dario Calderone, Davide Capodanno
Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack. Expert review of clinical pharmacology 15 (9) (2022)
Claudio Montalto, Renato Francesco Maria Scalise, Sergio Leonardi, Antonio Micari, Jacopo A Oreglia, Pascal Vranckx, Davide Capodanno, Jurriën Ten Berg, Renato Deláscio Lopes, Marco Valgimigli
Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials. European heart journal. Cardiovascular pharmacotherapy (2022)
Davide Capodanno, Antonio Greco
Dual antiplatelet therapy in patients at high bleeding risk: less is more-more or less. European heart journal (2022)
Davide Capodanno, Dominick J Angiolillo, Ryan J Lennon, Shaun G Goodman, Sang-Wook Kim, Fearghas O'Cochlain, Derek Y F So, John Sweeney, Charanjit S Rihal, Michael Farkouh, Naveen L Pereira
ABCD-GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial. Journal of the American Heart Association 11 (4) (2022)
Luis Ortega-Paz, Davide Capodanno, Dominick J Angiolillo
Canakinumab for secondary prevention of coronary artery disease. Future cardiology 17 (3) (2021)
Luca Saba, Brinjikji W, J David Spence, Max Wintermark, M Castillo, Gert J de Borst, Qi Yang, Chun Yuan, Andrew J Buckler, Myriam Edjlali, T Saam, David Saloner, Brajesh K Lal, Davide Capodanno, Jie Sun, Niranjan Balu, Ross Naylor, A V D Lugt, Bruce A Wasserman, Marianne Eline Kooi, Joanna Marguerite Wardlaw, J H Gillard, Giuseppe Lanzino, Ulf Hedin, David J Mikulis, Ajay Gupta, J Kevin DeMarco, Christopher P Hess, Johan W M Van Goethem, Thomas S Hatsukami, Peter M Rothwell, Martin M Brown, Alan R Moody
Roadmap Consensus on Carotid Artery Plaque Imaging and Impact on Therapy Strategies and Guidelines: An International, Multispecialty, Expert Review and Position Statement. AJNR. American journal of neuroradiology 42 (9) (2021)
Mattia Galli, Francesco Franchi, Fabiana Rollini, Larisa H Cavallari, Davide Capodanno, Filippo Crea, Dominick J Angiolillo
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations. Expert review of clinical pharmacology 14 (8) (2021)
Dario Calderone, Salvatore Ingala, Maria Sara Mauro, Dominick J Angiolillo, Davide Capodanno
Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events. Expert review of cardiovascular therapy 19 (12) (2021)
Antonio Greco, Davide Capodanno
Differences in coronary artery disease and outcomes of percutaneous coronary intervention with drug-eluting stents in women and men. Expert review of cardiovascular therapy 19 (4) (2021)
Paolo Calabrò, Felice Gragnano, Giampaolo Niccoli, Rossella Marcucci, Marco Zimarino, Carmen Spaccarotella, Giulia Renda, Giuseppe Patti, Giuseppe Andò, Elisabetta Moscarella, Massimo Mancone, Arturo Cesaro, Gennaro Giustino, Raffaele De Caterina, Roxana Mehran, Davide Capodanno, Marco Valgimigli, Stephan Windecker, George D Dangas, Ciro Indolfi, Dominick J Angiolillo
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease. Circulation 144 (16) (2021)
Marco Vitolo, Saad Javed, Davide Capodanno, Andrea Rubboli, Giuseppe Boriani, Gregory Yoke Hong Lip
Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis. Expert review of cardiovascular therapy 18 (9) (2020)
Antonio Greco, Marco Spagnolo, Davide Capodanno
Unmasking psychological reasons of delay in acute coronary syndromes presentation during the COVID-19 pandemic. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 98 (2) (2020)
Magnus J Hagnäs, Giuseppe Venuti, Carmelo Castellana, Giulio Piedimonte, Luigi Ferrarotto, Timo Mäkikallio, Davide Capodanno, Corrado Tamburino, Alessio La Manna
Does the left circumflex coronary artery location impact on the success of chronic total occlusion recanalization? A single-center cohort study. Scandinavian cardiovascular journal : SCJ 55 (2) (2020)
Mattia Galli, Davide Capodanno, Felicita Andreotti, Filippo Crea, Dominick J Angiolillo
Safety and efficacy of P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary interventions. Expert opinion on drug safety 20 (1) (2020)
Dario Calderone, Davide Capodanno, Dominick J Angiolillo
An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitus. Expert review of cardiovascular therapy 18 (8) (2020)